Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

NEUVÉ Health vs Vytora Health

In our scoring, Vytora Health edges ahead overall (8.4 vs 6.6 out of 10).

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

Key differences

Price
NEUVÉ Health $179/mo billed every 4 weeks; Vytora Health $179/mo no prepay listed (compounded semaglutide · not like-for-like, so neither is marked cheaper)
Coverage
Vytora Health 50 states + DC (NEUVÉ Health doesn't publish a state list)
Included
NEUVÉ Health: not stated; Vytora Health: medication, clinician visits, shipping

How we compare providers

NEUVÉ Health

Best for a broad catalog of GLP-1, hormone and peptide protocols under one brand

semaglutide

$179/mo

billed every 4 weeks · microdose plan

Our score 6.6/10

Vytora Health logo

Vytora Health

Best for compounded or brand-name GLP-1 with named pharmacy partners, 50 states

semaglutide

$179/mo

Our score 8.4/10

We may earn a commission if you sign up through these links. Partner status can affect which provider we feature; it never changes a score or a price.

Costs & coverage

Published prices with their terms attached. Yearly figures are modeled from the standing price and billing cadence. A check mark marks the better side, on like-for-like rows only.

NEUVÉ Health

Vytora Health

Price

Semaglutide / month

$179/mo

billed every 4 weeks · microdose plan

$179/mo

Semaglutide / year (modeled)

$2,327

13 charges

$2,148

Tirzepatide / month

$240/mo

billed every 4 weeks · microdose plan

$249/mo

Tirzepatide / year (modeled)

$3,120

13 charges

$2,988

Oral tirzepatide / month

$282/mo

billed every 4 weeks

Not listed

Brand Zepbound / Mounjaro / month

Not listed

$1,399/mo

Coverage

State availability

List not published

50 states + DC

Oral option listed

Yes

Not listed

Brand-name access listed

Not listed

Zepbound / Mounjaro

Included in the price

Not disclosed

Medication, clinician visits, shipping

Terms & safety

Price shown

Plan quoted after intake; a price is published

Before intake

Cancel anytime

Not disclosed

Yes

Minimum commitment

Not disclosed

None on monthly plans; 3-month plans are billed every 3 months

Refunds

Not disclosed

'All sales are final' for prescription products; refund requests 'reviewed on a case-by-case basis'

FDA warning letters

None on record

None on record

Provider facts checked

November 2026

October 2026

Every dose and plan: NEUVÉ Health · Vytora Health

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 540+ providers' prices on their own sites and email you when tracked prices move.

Which fits your priorities?

Only the points where these two differ, from the table above and each provider’s record.

Choose NEUVÉ Health if…

  • Lists oral compounded tirzepatide, which Vytora Health doesn't price
  • Shows three named plans with prices immediately after intake, rather than making you create an account first
  • States that there is no consultation fee and no charge until a licensed clinician approves the plan

What to weigh up

  • No published state list; confirm yours at signup
  • Contradicts itself on whether medication is included: the fine print says billed separately, while the What-s Included panel says included
Vytora Health logo

Choose Vytora Health if…

  • Lists brand-name Zepbound / Mounjaro, which NEUVÉ Health doesn't price
  • Publishes its full state list (50 states + DC)
  • Both compounded and brand-name options on one platform

What to weigh up

  • Brand-name Mounjaro and Zepbound at $1,399/mo are priced at retail; manufacturer self-pay programs are often cheaper
  • Compounded tirzepatide at $249/mo month-to-month is mid-market

NEUVÉ Health and Vytora Health in context

NEUVÉ Health and Vytora Health both list compounded semaglutide, yet the figures are not like-for-like: one figure is a microdose plan. We leave the cheaper-side call out rather than guess. For a like-for-like field, see the cheapest compounded semaglutide ranking. On score, NEUVÉ Health is at 6.6 and Vytora Health at 8.4 out of 10.

NEUVÉ Health raises its price with the dose, and Vytora Health does not state how its price moves, so ask both for the maintenance-dose figure. Why GLP-1 doses step up over time explains the schedule you would be paying through. Only NEUVÉ Health lists a pill (oral compounded tirzepatide). If avoiding injections is the point, read oral vs injectable GLP-1s before choosing on price. Vytora Health publishes where it ships (50 states + DC); NEUVÉ Health does not publish a state list, so confirm yours at intake or start from providers by state.

The next head-to-head for NEUVÉ Health is NEUVÉ Health vs Amazon One Medical; Amazon One Medical sells orforglipron and semaglutide and lists 50 states. For Vytora Health, it is Vytora Health vs New Tides; New Tides sells semaglutide and tirzepatide and lists 45 states + DC. If neither fits, the wider shortlists are alternatives to NEUVÉ Health and alternatives to Vytora Health.

Explore the scoring factors

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

NEUVÉ Health

6.6/10

Overall

Vytora Health

8.4/10

Value25%

6.5A
vs
B
8.0

Effectiveness25%

7.0A
vs
B
8.5

User Experience15%

7.2A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
9.3

Accessibility10%

6.5A
vs
B
8.5

Support10%

6.2A
vs
B
8.4

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

8.3

CoreAge Rx

Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

Read full review →

From $79/mo (“starting at” price)

Get started →
7.8

Embody

Low flat-rate compounded GLP-1 pricing at every dose

Read full review →

From $79/mo (sale price)

Get started →
8.2

Gala

Compounded semaglutide or tirzepatide at one all-doses price on a yearly plan, with free shipping

Read full review →

From $129/mo (starting dose)

Get started →

NEUVÉ Health vs Vytora Health: FAQ

Vytora Health scores higher overall at 8.4/10 versus 6.6/10, and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. That said, NEUVÉ Health is a better fit if you want a broad catalog of GLP-1, hormone and peptide protocols under one brand.
Neither NEUVÉ Health nor Vytora Health is currently an affiliate partner, so we earn no commission from either. We rank all providers editorially using the same six-dimension framework and disclose any commercial relationships.
NEUVÉ Health: $179 (billed every 4 weeks, 13 charges a year), about $2,327 a year. Vytora Health: $179, about $2,148 a year. Not like-for-like: one figure is a microdose plan.
NEUVÉ Health doesn't publish a state list. Vytora Health publishes 50 states + DC. Where a list isn't published, confirm your state during sign-up before paying.
NEUVÉ Health doesn't state its cancellation terms. Vytora Health: cancel anytime (yes), minimum commitment (None on monthly plans; 3-month plans are billed every 3 months), early-cancellation fee (not disclosed). Check the provider's own terms before you buy.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring NEUVÉ Health and Vytora Health head-to-heads in the same category.

Or see the full category ranking, or alternatives to NEUVÉ Health and Vytora Health.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.